How industry led accelerators must change their value proposition to increase success rate of partnerships
80% of digital health partnerships are frequently destined to fail. Accelerators have been one of the most used tools for the healthcare industry to initiate partnerships. Industry led accelerators in particular have been promising to improve partnership success ratio, but they have to change their value proposition. 1 out of 5 partnerships in digital health Learn more...
How a mobile app delivers digital therapeutics to enhance behaviour health and empower kids throughout their chronic condition journey – Interview with Dr. Haljas, CEO of Triumf Health
Digital health care and digital therapeutics providers lead a new chapter in healthcare by utilizing technology to enhance patient care. Personalized patient management programs with novel therapies and services aimed at changing behaviour and influence disease can play a prominent role in assisting patients in a wide range of chronic conditions. 60% of chronically ill Learn more...
How the German “Fast Track” for digital solutions impacts market entry channels
Germany’s new “Fast Track” for digital health applications will also have a positive impact on other market entry channels. Health insurers and hospitals will professionalize their digital health offerings to stay in the driver seat. The direct-to-consumer channel will support HCPs’ uptake. Starting from April 2020, patient-oriented digital health applications can apply for this new Learn more...
Why Asia and Europe are still an untapped market opportunity for digital women’s health vendors, in contrast to the USA
The adoption rate of digital women’s health solutions, such as Clue, Glow or Ovia, has exceeded 20% of the addressable market in the USA. In contrast, fertility trackers or pregnancy solutions have so far hardly been used in Asian countries. Market entry options in those markets and selected EU countries might be better due to Learn more...
3 months after the launch of R2GConnect, more than 500 early stage digital health start-ups applied for partnerships
R2GConnect, the new global matching platform focusing on the digital health industry presents partnership opportunities for any start-ups at all stages. Over the last 3 months, more than 500 early stage start-ups and innovators in digital health have sought the platform for partnerships with various health accelerators, incubators, corporates and health event organizers. R2GConnect has Learn more...
Apple and Google have sparked the competition in the global digital women’s health ecosystem. How to react?
The competition level in the digital women’s health ecosystem has increased over the last two years. First service offerings of tech giants like Apple and Alphabet are already affecting the performance of established market players. Companies will need to expand their service offerings and explore new revenue sources to stay competitive. The digital women’s health Learn more...
New partnership opportunities from the European Commission and Global Health Accelerators await the digital health startups and innovators
R2GConnect has been working with various partners such as health accelerators and incubators that helped a lot of startups over time. The year 2020 is no different. New partners have joined the platform and ready to provide investment to startups that meet their qualifications: The European Commission has launched the European Council on Innovation Accelerator Learn more...
Digital women’s health market will reach US$297 million in 2024, targeting 1.4 billion women worldwide
The global market for digital women’s health solutions and services will grow from today’s US$112 million to US$297 million in 2024, at 22% on average annually (CAGR). There will be 1.46 billion women who can be targeted with digital women’s health solutions in 5 years from now, as the new report about digital women’s health Learn more...
Success drivers for digital health partnerships. Learnings from R2G’s new global study and recent failures of Sandoz, Otsuka, and Sanofi
In the last quarter of 2019, three major pharma companies pulled out of their seemingly promising partnerships within digital health. Following the announcements regarding partnerships withdrawal between Sandoz and Pear, Otsuka Pharmaceutical and Proteus, and Sanofi and Onduo (a joint venture with Verily), R2G reviews reasons behind these developments, compares them to the results of Learn more...